Advocacy

Advocacy

New EGFR Resisters Branded Hoodies, Sweatshirts, Colors, and Slogans!

*September 2023* As you may know, the EGFR Resisters are partnering with LUNGevity for 2 more research projects that are focused on EGFR+ lung cancer research. Since we launched our shirt sales fundraising campaign, we have added an additional $1,521 to our funds so please keep your family and friends…

laurabbook@gmail.comSeptember 29, 2023

Advocacy

Patients with Brain Metastases Deserve Better—A Hard-Won Perspective

*July 2023* This article is written by Laura Greco, a lung cancer patient and advocate. It has been observed that “the development of brain metastases is one of the most feared complications of cancer due to the substantial neurocognitive morbidity and a grim prognosis.”1 In my own case, when I…

laurabbook@gmail.comSeptember 29, 2023

Advocacy Coping With Cancer

Passing of The Baton—On the Death of Patient Research Advocates

*January 2023* By Angus Pratt When I was diagnosed with lung cancer in 2018, there was a small community of patient research advocates—or PRAs. We were a small community because most of us did not live long enough to get involved in advocacy. Fortunately, now we are surviving longer, which…

laurabbook@gmail.comFebruary 3, 2023

Advocacy Funding Research

Video Summary Recap: 2022 EGFR Resisters Research Summit

*December 2022* The EGFR Resisters held our 4th Annual 2022 EGFR Resisters Research Summit on November 17-18, 2022 in Chicago. Please watch this video to learn more about the summit and the lung cancer research presented by the Young Investigators who participated.

laurabbook@gmail.comDecember 19, 2022

Advocacy Funding

Lung Cancer Research Foundation (LCRF) and EGFR Resisters Announce Research Awards

*December 2022* The EGFR Resisters are thrilled to announce the THREE 2022 grant recipients of our research award partnership with Lung Cancer Research Foundation. Each project will receive $150,000 for 2 years, for a total of $450,000 of funding. Please read the press release here for more details about the…

laurabbook@gmail.comDecember 19, 2022

Advocacy Research

Epidemiology of Young Lung Cancer Study

*October 2022* Given all the exciting news out of ESMO about mechanisms of air pollution coupled with EGFR mutation, the GO2 Foundation for Lung Cancer and ALCMI want to re-flag this study! They are hoping to be able to do an interim analysis in time for ASCO 2023 and need…

laurabbook@gmail.comOctober 30, 2022

Advocacy Research Treatments

What is Meant by “Informed Consent”?

*August 2022* By EGFR Resisters Co-founder Ivy Elkins for Lungcancer.net Unless you have participated in a clinical trial, you might not be familiar with the term “informed consent,” commonly used to refer to the document that patients are given when they are considering signing up for a trial. This document…

laurabbook@gmail.comSeptember 24, 2022

Advocacy

FDA Workshop: Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics

*May 2022* EGFR Resisters co-founder Jill Feldman participated as a panelist in this FDA Oncology Workship: 3a "Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics; and 3b "Opportunities to Improve Dose Optimization: Assessing Safety and Tolerability." Current strategies for determining the recommended dose(s) of anticancer agents for evaluation…

laurabbook@gmail.comJuly 3, 2022

Jill Feldman - EGFR resisters group founder

Advocacy

I Don’t Want to Survive, I Want to Live

*April 2022* Video: Jill Feldman, co-founder of the EGFR Resisters and Stage 4 lung cancer survivor since 2009, speaks about survivorship at ELCC. Even care Watch video here.

laurabbook@gmail.comJune 29, 2022

Advocacy

Keeping Your Work Focused on Patients, Ivy Elkins, presenter

*February 2022* EGFR Resisters Co-Founder Ivy Elkins gave a presentation on “Keeping Your Work Focused on Patients" at the IASLC 2022 Targeted Therapies of Lung Cancer Meeting. This presentation was part of a special Early Career Workshop aimed at young investigators and focused on critical topics of interest to them…

laurabbook@gmail.comMarch 23, 2022

New EGFR Resisters Branded Hoodies, Sweatshirts, Colors, and Slogans!

Patients with Brain Metastases Deserve Better—A Hard-Won Perspective

Passing of The Baton—On the Death of Patient Research Advocates

Video Summary Recap: 2022 EGFR Resisters Research Summit

Lung Cancer Research Foundation (LCRF) and EGFR Resisters Announce Research Awards

Epidemiology of Young Lung Cancer Study

What is Meant by “Informed Consent”?

FDA Workshop: Opportunities to Improve Dose Optimization: Designing Trials and Applying Pharmacometrics

I Don’t Want to Survive, I Want to Live

Keeping Your Work Focused on Patients, Ivy Elkins, presenter

GIVE TODAY

Categories

STAY CONNECTED

You Might Like

BECOME A MEMBER

QUICK LINKS

WHO WE ARE

PROJECTS

ALLIANCES & RESOURCES